Azithromycin inhibits nontypeable Haemophilus influenzae-induced MUC5AC expression and secretion via inhibition of activator protein-1 in human airway epithelial cells.

[1]  Yasuaki Yamada,et al.  Azithromycin, clarithromycin and telithromycin inhibit MUC5AC induction by Chlamydophila pneumoniae in airway epithelial cells. , 2009, Pulmonary pharmacology & therapeutics.

[2]  K. Yanagihara,et al.  Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. , 2008, The Journal of antimicrobial chemotherapy.

[3]  Kensei Komatsu,et al.  Glucocorticoids inhibit nontypeable Haemophilus influenzae-induced MUC5AC mucin expression via MAPK phosphatase-1-dependent inhibition of p38 MAPK. , 2008, Biochemical and biophysical research communications.

[4]  P. Hutchinson,et al.  Cytotoxic T lymphocyte and natural killer cell responses to non‐typeable Haemophilus influenzae , 2008, Clinical and experimental immunology.

[5]  R. Wu,et al.  Regulation of airway mucin gene expression. , 2008, Annual review of physiology.

[6]  Jian-Dong Li,et al.  Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae. , 2008, Biochemical and biophysical research communications.

[7]  Ke Wang,et al.  Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF‐κB , 2008, Respirology.

[8]  S. Kohno,et al.  Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells , 2007, Clinical and experimental immunology.

[9]  B. Assael,et al.  Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. , 2006, Biochemical and biophysical research communications.

[10]  H. Kubo,et al.  Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells , 2006, Respiratory Physiology & Neurobiology.

[11]  A. Torres,et al.  Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.

[12]  Jian-Dong Li,et al.  Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKβ- IκBα-NF-κB signaling pathways , 2004 .

[13]  Y. Hirakata,et al.  Azithromycin Inhibits MUC5AC Production Induced by the Pseudomonas aeruginosa Autoinducer N-(3-Oxododecanoyl) Homoserine Lactone in NCI-H292 Cells , 2004, Antimicrobial Agents and Chemotherapy.

[14]  Jian-Dong Li,et al.  Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. , 2004, Biochemical and biophysical research communications.

[15]  M. Rosenthal,et al.  Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial , 2002, The Lancet.

[16]  S. Bell,et al.  Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial , 2002, Thorax.

[17]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[18]  Jiahuai Han,et al.  Novel Cytoplasmic Proteins of Nontypeable Haemophilus influenzae Up-regulate Human MUC5AC Mucin Transcription via a Positive p38 Mitogen-activated Protein Kinase Pathway and a Negative Phosphoinositide 3-Kinase-Akt Pathway* , 2002, The Journal of Biological Chemistry.

[19]  C. Basbaum,et al.  Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells , 2002, Nature Medicine.

[20]  H. Kaida,et al.  [Two cases successfully treated with long-term administration of low-dosage azithromycin]. , 2001, The Japanese journal of antibiotics.

[21]  E. Mason,et al.  Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. , 2001, American journal of respiratory and critical care medicine.

[22]  M. Yamaya,et al.  Erythromycin and common cold in COPD. , 2001, Chest.

[23]  A. Smith,et al.  Acid phosphatase activity as a measure of Haemophilus influenzae adherence to mucin. , 1999, Journal of microbiological methods.

[24]  A. Cripps,et al.  Nontypeable Haemophilus influenzae: Pathogenesis and Prevention , 1998, Microbiology and Molecular Biology Reviews.

[25]  S. Kudoh,et al.  Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. , 1998, American journal of respiratory and critical care medicine.

[26]  Jian-Dong Li,et al.  Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. , 1998, Biochimica et biophysica acta.

[27]  L. Duffy,et al.  Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first two years of life. , 1996, Acta oto-laryngologica. Supplementum.

[28]  M. Fukakusa,et al.  [Study on azithromycin in treatment of diffuse panbronchiolitis]. , 1995, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.